Eğitim Bilgileri

  • 1991 - 1997

    Doktora, İSTANBUL ÜNİVERSİTESİ, Cerrahpaşa tıp fakültesi

  • 1998 - 2003

    Tıpta Uzmanlık, Bezmialem Valide Sultan Eğitim ve Araştırma Hastanesi, İç hastalıkları

  • 2016

    Fitoterapi Sertifikası, Bezmialem Vakıf Üniversitesi

  • 2016 - Halen...

    Başhekim Yardımcısı, BEZMİÂLEM VAKIF ÜNİVERSİTESİ

Eserler ve Yayın Listesi

SCI,SSCI,AHCI İNDEKSLERİNE GİREN DERGİLERDE YAYINLANAN MAKALELER

  • Zorlu M., Kiskac M., Çakirca M., Karatoprak C., Güler E., Celik K., et al., “Evaluation of the Relation between Vitamin D and Serum Omentin and Vaspin Levels in Women.”, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.124, pp.440-3, 2016
    Cikrikcioglu M., Sekin Y., Halac G., Kilic E., Kesgin S., Aydin S., et al., “Reduced bone resorption and increased bone mineral density in women with restless legs syndrome.”, NEUROLOGY, vol.86, pp.1235-41, 2016
    Cikrikcioglu M., Soytas R., Kilic E., Toprak A., Çakirca M., Zorlu M., et al., “CD40 ligand and P-selectin in heterozygous Beta-thalassemia.”, JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, vol.66, pp.699-704, 2016
    Zorlu M., Kiskaç M., Çakirca M., Karatoprak C. , Güler E.M., Celik K., et al.,”Evaluation of the Relation between Vitamin D and Serum Omentin and Vaspin Levels in Women”, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.124, pp.440-443, 2016 (Link)
    Cikrikcioglu M.A., Soytas R.B., Kilic E., Toprak A.E., Çakirca M., Zorlu M., et al., “CD40 ligand and p-selectin in heterozygous beta-thalassemia”, JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, vol.66, pp.699-704, 2016
    Celik K., Cikrikcioglu M., Halac G., Kilic E., Ayhan S., Ozaras N., et al., “Serum endocan levels in women with restless legs syndrome.”, NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol.11, pp.2919-25, 2015
    Erkoc R., Cikrikcioglu M., Aintab E., Toprak A., Kilic U., Gok O., et al., “GAS6 intron 8 c.834 + 7G > A gene polymorphism in diabetic nephropathy.”, RENAL FAILURE, vol.37, pp.866-70, 2015
    Kiskac M., Zorlu M., Çakirca M., Büyükaydin B., Karatoprak C., Yavuz E., “Frequency and determinants of erectile dysfunction in Turkish diabetic men.”, NIGERIAN JOURNAL OF CLINICAL PRACTICE, vol.18, pp.209-12, 2015
    Çakirca M., Karatoprak C., Ugurlu S., Zorlu M., Kıskaç M., Çetin G., “Parvovirus B19 infection as a cause of acute myositis in an adult.”, REVISTA BRASILEIRA DE REUMATOLOGIA, vol.55, pp.185-8, 2015
    Karatoprak C., Kilicarslan R., Çakirca M., Aydin S., Ozkan T., Kocaman O., et al., “Effects of 18-Month Vildagliptin Treatment on Portal Vein Pressure”, DIABETES, vol.64, pp.A663-A663, 2015
    Kiskac M., Zorlu M., Akkoyunlu M., Kilic E., Karatoprak C., Çakirca M., et al., “Vaspin and lipocalin-2 levels in severe obsructive sleep apnea.”, JOURNAL OF THORACIC DISEASE, vol.6, pp.720-5, 2014
    Kiskac M., Zorlu M., Çakirca M., Karatoprak C., Kesgin S., Büyükaydin B., et al., “Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.”, ANNALES D ENDOCRINOLOGIE, vol.75, pp.200-5, 2014
    Zorlu M., Kiskac M., Karatoprak C., Kesgin S., Çakirca M., Yildiz K., et al., “Assessment of serum apelin and lipocalin-2 levels in patients with subclinical hypothyroidism.”, ANNALES D ENDOCRINOLOGIE, vol.75, pp.10-4, 2014
    Çakirca M., Karatoprak C. , Zorlu M., Kiskaç M., Kanat M., Cikrikcioglu M.A., et al.,”Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients”, DRUG DESIGN DEVELOPMENT AND THERAPY, vol.8, pp.239-243, 2014
    Cikrikcioglu M., Karatoprak C., Çakirca M., Kiskac M., Zorlu M., Cetin G., et al., “Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease.”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2530-7, 2013
    Kiskac M., Zorlu M., Çakirca M., Karatoprak C., Peru C., Erkoc R., et al., “A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.”, INDIAN JOURNAL OF PHARMACOLOGY, vol.45, pp.305-6, 2013
    Karatoprak C., Yolbas S., Çakirca M., Cinar A., Zorlu M., Kiskac M., et al., “The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus.”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2512-6, 2013
    Zorlu M., Kiskac M., Karatoprak C., Çakirca M., Yavuz E., Cetin G., et al., “Pott’s disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy.”, INDIAN JOURNAL OF PHARMACOLOGY, vol.45, pp.631-3, 2013
    Cikrikcioglu M.A., Karatoprak C., Çakirca M., Kiskac M., Zorlu M., Cetin G., et al., “Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2530-2537, 2013
    Karatoprak C., Yolbas S., Çakirca M., Cinar A., Zorlu M., Kiskac M., et al., “The effects of long term fasting in Ramadan on glucose regulation in type 2 Diabetes Mellitus”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2512-2516, 2013
    Karatoprak C., Yolbas S., Kiskaç M., Zorlu M., Yay A., Çakirca M., et al., “The effects of short-acting analogue insulins on body weight in patients with type 2 diabetes mellitus”, TURKISH JOURNAL OF MEDICAL SCIENCES, vol.43, pp.268-272, 2013
    Cikrikcioglu M., Soysal P., Dikerdem D., Çakirca M., Kazancioglu R., Yolbas S., et al., “Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure.”, EUROPEAN JOURNAL OF EMERGENCY MEDICINE, vol.19, pp.257-63, 2012
    Hursitoglu M., Tukek T., Cikrikcioglu M., Kara O., Kazancioglu R., Ozkan O., et al., “Urotensin II levels in patients with chronic kidney disease and kidney transplants.”, UPSALA JOURNAL OF MEDICAL SCIENCES, vol.117, pp.22-7, 2012
    Uyanikoglu A., Akyuz F., Ermis F., Arici S., Bas G., Çakirca M., et al., “Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique.”, JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, vol.18, pp.187-93, 2012
    Cikrikcioglu M., Halac G., Hursitoglu M., Erkal H., Çakirca M., Kinas B., et al., “Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome.”, ACTA NEUROLOGICA BELGICA, vol.111, pp.282-6, 2011
    Cikrikcioglu M., Hursitoglu M., Erkal H., Kinas B., Sztajzel J., Çakirca M., et al., “Oxidative stress and autonomic nervous system functions in restless legs syndrome.”, EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, vol.41, pp.734-42, 2011
    Hursitoglu M., Tukek T., Cikrikcioglu M.A., Kara O., Kazancioğlu R., Ozkan O., et al., “UROTENSIN II LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND KIDNEY TRANSPLANTS”, TRANSPLANT INTERNATIONAL, vol.24, pp.289-289, 2011
    Cikrikcioglu M.A., Halac G., Hursitoglu M., Erkal H., Çakirca M., Kinas B.E., et al., “Prevalence of Gluten Sensitive Enteropathy antibodies in Restless Legs Syndrome”, ACTA NEUROLOGICA BELGICA, vol.111, pp.282-286, 2011
    Uyanikoglu A., Akyuz F., Bas G., Çakirca M., Baran B., Ermis F., et al., “Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique”, GASTROINTESTINAL ENDOSCOPY, vol.71, pp.AB268-AB268, 2010
    Cikrikcioglu M., Hursitoglu M., Erkal H., Inan B., Ozturk T., Çakirca M., et al., “Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.”, PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, vol.37, pp.104-9, 2010
    Hursitoglu M., Çakirca M., Cikrikcioglu M.A., Tukek T., “The interferon-gamma-based QuantiFERON®-TB Gold In-Tube test and the type of haemodialysis process”, SWISS MEDICAL WEEKLY, vol.140, pp.388-388, 2010
    Hursitoglu M., Çakirca M., Cikrikcioglu M.A., Tukek T., “The interferon-gamma-based QuantiFERON (R)-TB Gold In-Tube test and the type of haemodialysis process”, SWISS MEDICAL WEEKLY, vol.140, pp.388-388, 2010
    Cikrikcioglu M.A., Elik I., Hursitoglu M., Erkal H., Çakirca M., Kurt T., et al., “The Prevalence of Low T3 With Arrhythmia and Heart Failure in Patients With Acute Coronary Syndrome”, ENDOCRINOLOGIST, vol.20, pp.23-26, 2010
    Uyanikoglu A., Davudoglu C., Çakirca M., Danalioglu A., “Is peptic ulcer incidence decreasing?”, NOBEL MEDICUS, vol.5, pp.15-17, 2009

DİĞER DERGİLERDE YAYINLANAN MAKALELER

  • Karatoprak C., Kilicarslan R., Çakirca M., Aydin S., Ozkan T., Kocaman O., et al., “Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus”, BEZMIALEM SCIENCE, vol.6, pp.1-5, 2018
    Karatoprak C., Arabaci E., Yildiz K., Çakirca M., Cikrikcioglu M., Ergun F., et al., “Gastroenterology cases of cutaneous leukocytoclastic vasculitis.”, Case reports in medicine, vol.2013, pp.264189-264189, 2013

HAKEMLİ KONGRE / SEMPOZYUMLARIN BİLDİRİ KİTAPLARINDA YER ALAN YAYINLAR

  • Çakirca M., “”, , TURKİYE,
    Karatoprak C., Batar N., Zorlu M., Çakirca M., Kiskaç M., “obezlerde tempolu yürüyüş sıklığı ile metabolik parametreler arasındaki ilişki”, 19.ulusal iç hastalıkları kongresi, TÜRKIYE,

KİTAP ve KİTAP BÖLÜMLERİ

Çakirca M., “Urinary incontinance”, in: New Horizons in Geriatric Medicine, Işık A.T., Mas R., Karan M.A.,, . Grossberg G.T., Eds., Nova Biomedical, Sience Publishers, Newyork, pp.3-14, 2013 (Link)

Doç. Dr. Mustafa ÇAKIRCA'ya Soru Sor..

Şeker Hastalığı, Metabolik Sendrom, Yüksek Tansiyon, Kolesterol, Trigliserid,  Aşıeı Şişmanlık, Kan Hastalıkları, Tiroid Bezi Hastalıkları, Mide, Bağırsak Hastalıkları, Bitkisel Tedavi ve daha bir çok konuda aklınıza takılan her şeyi  Doç. Dr. Mustafa Çakırca’ya sorun….